News

14-12-2018
Within the InfectControl 2020 FINAR BMBF-project the selection for resistances is captured for the first time systematically by specialists coming from the fields of phytopathology, veterinary medicine and infection biology. 

Learn more

 

13-12-2018
SYNLAB Pharma, a subsidiary of SYNLAB Holding Deutschland GmbH announces that it has signed a collaboration agreement with Biotype with the intention to offer a Europe-wide clinical trial service for MSI and POLE/POLD1 mutation detection to indicate if patients harboring from GI cancer or EC would benefit from immune checkpoint inhibitor therapy.

Learn more

 

01-06-2017
Since it was founded in 1999, Biotype Diagnostic GmbH has established an international position developing and marketing outstanding molecular diagnostics systems in the fields of forensics, dermatology and leukaemia. Another mainstay is producing complex testing systems commissioned by global players such as QIAGEN GmbH. Now, Biotype is extending its OEM business and exceptional skills in developing and producing made-to-order multiplex PCR assays in new fields.

Read more

 

14-03-2017
The new assays DigitalScreen/DigitalQuant of the Biotype Diagnostic GmbH ensure a robust and highly sensitive evaluation of disease progression after stem cell transplantation based on the innovative digital PCR technology.

Read more

 

23-02-2016
Quantitative Strategy for Chimerism Monitoring – new method provides significant increase in sensitivity by factor 20 which translates into massive time advantage

Read more
 

 

18-01-2016
50 molecular markers combined with highest sensitivity result in a dramatic improvement of chimerism monitoring

Read more